HomeGeneral NewsJohns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis

Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis

April 9, 2026

- Advertisement -

Artist’s illustration of tuberculosis bacteria (TB) – credit, US CDC

A research team at Johns Hopkins Medicine is developing a nose-delivered inoculation against tuberculosis, the world’s leading cause of death from infectious disease.

The approach fuses two tuberculosis genes…

Click here to view the original article.

Tags
Good News
Goodnewsnetwork.org

- Advertisment -

K-pop without the K: BTS’ English-heavy comeback sparks debate over cultural identity

The Best Skin Care for Sensitive Skin Won’t Irritate Your Face

Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis

Recently Viewed

Netanyahu Arrest: Mamdani Team Considered How to Pivot Away From Campaign Pledge During Mayoral Transition

'No support network': the crushing isolation of being stuck on your street

Tactical Resources Announces Exchange Ratio for Business Combination with Plum Acquisition Corp. III

Aus council’s plan to sell $750k of land for $1

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

The Most Popular Islands Destinations Right Now

Ageing signs: How to tell how much you’re ageing and if you’re ageing well

Morgans recommends 3 ASX shares to buy

POPULAR CATEGORY

FOLLOW US

Johns Hopkins Team Develops Therapeutic, Nasally-Delivered DNA Vaccine for Tuberculosis

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US